Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Marker Therapeutics Announces Upcoming Presentations on MT-601 in Relapsed Non-Hodgkin and Hodgkin Lymphoma at the 67th ASH Annual Meeting
-
Beyond Meat® Introduces New Value Pack of Its Latest Beyond Beef® at Retailers Across Canada
-
UTime Limited Explores Application of AI Technology in Health Data Analysis
-
VERSES Announces Financing Agreement with a Notional Value of CAD$14 Million and Reduces Staff to Streamline Operations
-
Kura Oncology and Kyowa Kirin Announce Presentations of Ziftomenib Ven/Aza Combination Data in Frontline and Relapsed/Refractory NPM1-m or KMT2A-r Acute Myeloid Leukemia at 2025 ASH Annual Meeting
-
Marine Thinking to Become a Publicly Traded Company on NASDAQ via Combination with Eureka Acquisition Corp.
-
Lendmark Financial Services Raises $2.1M for Childhood Cancer Research During its 10th anniversary ‘Climb to Cure’ Campaign
-
Cullinan Therapeutics to Showcase New Data Demonstrating Compelling Clinical Activity for CLN-049, a Novel FLT3xCD3 T Cell Engager, in AML Patients in an Oral Presentation at the 67th ASH Annual Meeti
-
CBP Management Enters Third Atlantic Province with New PEI Mandate
-
Stablecon and Events Venture Group Announce Strategic Investment and European Expansion with New EMEA Conference in Amsterdam
-
Man Group PLC : Form 8.3 - Unite Group plc
-
Syndax to Host ASH Investor Event in Person and via Webcast on December 8, 2025
-
Syndax Announces Compelling Revuforj® (revumenib) and Niktimvo™ (axatilimab-csfr) Data Accepted for Presentation at ASH 2025
-
Autolus Therapeutics to Present Clinical Data Updates at the American Society of Hematology (ASH) Annual Meeting 2025
-
Senti Bio to Present Updated Clinical Results of First-in-Class Logic Gated CD33/FLT3 Cell Therapy, SENTI-202, at the American Society of Hematology (ASH) Annual Meeting 2025
-
Terns Announces Abstract with Positive Clinical Data for TERN-701 in Relapsed/Refractory CML Selected for Oral Presentation at 67th ASH Annual Meeting
-
UAB “Atsinaujinančios energetikos investicijos” publishes its factsheet for the third quarter of 2025
-
Genmab to Showcase Latest Blood Cancer Treatment Advancements at 2025 American Society of Hematology (ASH) Annual Meeting
-
Allogene Therapeutics Announces ALPHA3 Trial-in-Progress Poster Presentation at ASH Annual Meeting
-
Stop & Shop Steps Up to Fight Hunger this Holiday Season with a New Chapter for Its Signature Turkey Express Giving Program
-
Stop & Shop Steps Up to Fight Hunger this Holiday Season with a New Chapter for Its Signature Turkey Express Giving Program
-
Corvus Pharmaceuticals to Present Final Data from Soquelitinib Phase 1/1b T Cell Lymphoma Trial at the 67th American Society of Hematology Annual Meeting & Exposition
-
AI/R’s Avenue Code Launches ChatGPT Commerce Solution
-
New ROG XG Mobile eGPU Brings Desktop-Class Power to Laptops and Handhelds
-
Cogent Biosciences Reports Recent Business Highlights and Third Quarter 2025 Financial Results
-
Agios to Present New Mitapivat Data in Rare Blood Disorders at 67th ASH Annual Meeting and Exposition
-
Air Canada and the Air Canada Foundation Celebrate Another Successful Year of Autism Aviation Days Events Across the Country
-
Cogent Biosciences Announces Multiple Presentations at the 67th Annual American Society of Hematology (ASH) Meeting
-
General Mills Celebrates 28 Years with Team Canada, Launching Limited Edition Packaging for Milano Cortina 2026
-
Consolidated Water Wins $11.7 Million Contract to Build Wastewater Recycling Plant for San Francisco Bay Area Golf Club
-
MKS Inc. to Participate in Baird Global Industrial Conference
-
TRUNNANO Breaks Through Key Technology for Reaction Sintered Silicon Carbide Ceramics
-
Aptose Tuspetinib Clinical Data from Ongoing TUSCANY Trial in Newly Diagnosed AML Selected for Presentation at the 2025 ASH Annual Meeting
-
Prairie Provident Announces Completion of Preferred Share Financing and Debt Amendments
-
SELLAS Life Sciences Announces Presentation of Phase 2 Data of SLS009 in Combination with Azacitidine and Venetoclax in Relapsed/Refractory AML with MDS-Related Changes (AML-MR) at the 2025 American S
-
Prelude Therapeutics Announces Publication of Abstracts for Presentation at the American Society of Hematology 67th Annual Meeting
-
Cloudera Named A Leader in 2025 Data Fabric Platforms Report by Independent Analyst Firm
-
Galecto to Highlight GB3226 Program at ASH 2025
-
New Burixafor Clinical Data to be Presented as an Oral Presentation at the 2025 ASH Annual Meeting
-
Claude can now run instant research with GWI
-
Tessera Therapeutics to Present New Preclinical Data From In Vivo Programs for Sickle Cell Disease and T Cell Therapies at the 67th American Society of Hematology Annual Meeting
-
March Biosciences Announces Oral Presentation of MB-105 Interim Phase 2 Clinical Data at American Society of Hematology Annual Meeting
-
SAGA Metals Provides Update on Double Mer Uranium Project: A Well-Positioned Asset in North America as the Uranium Boom Accelerates
-
Nurix Therapeutics Announces Presentations at the 67th American Society of Hematology (ASH) Annual Meeting
-
IPSIPAY to launch next-generation Crypto Payment Platform
-
JAKKS Pacific and SEGA of America Renew Global Toy Partnership for Sonic the Hedgehog™ Merchandise
-
Evaxion expands R&D pipeline with new AI-designed precision cancer vaccine candidate
-
SEGG Media’s Racing Women Make History at the Yas Marina Circuit with First-Ever Female Podium in 2025/26 Gulf Radical Cup
-
Introducing Magic InBra™: Medela’s Lightest and Most Advanced Wearable Breast Pump in the U.S.
-
Tokyo Lifestyle Co., Ltd. Announces Grand Opening of Directly-Operated Reiwatakiya Store in Vietnam, Accelerating Expansion Across Southeast Asia
